Journal club: “Racial disparities in catheter related urinary tract infections among elderly trauma patients in the US”

2022 ◽  
Vol 50 (1) ◽  
pp. 120-121
Author(s):  
Diana Cervantes ◽  
Hillary Hei
Keyword(s):  
Urinary Tract ◽  
Racial Disparities ◽  
Urinary Tract Infections ◽  
Journal Club ◽  
Trauma Patients ◽  
The Us ◽  
Tract Infections ◽  
Elderly Trauma Patients

Racial disparities in catheter related urinary tract infections among elderly trauma patients in the US

2022 ◽  
Vol 50 (1) ◽  
pp. 77-80
Author(s):  
Ryan J. Keneally ◽  
Jonathan H. Chow ◽  
Raymond A. Pla ◽  
Eric R. Heinz ◽  
Michael A. Mazzeffi
Keyword(s):  
Urinary Tract ◽  
Racial Disparities ◽  
Urinary Tract Infections ◽  
Trauma Patients ◽  
The Us ◽  
Tract Infections ◽  
Elderly Trauma Patients

scholarly journals A prospective analysis of urinary tract infections among elderly trauma patients

2015 ◽  
Vol 79 (4) ◽  
pp. 638-642 ◽  
Author(s):  
Martin D. Zielinski ◽  
Melissa M. Kuntz ◽  
Stephanie F. Polites ◽  
Andy Boggust ◽  
Heidi Nelson ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Prospective Analysis ◽  
Trauma Patients ◽  
Tract Infections ◽  
Elderly Trauma Patients

Short-duration treatment for catheter-associated urinary tract infections in critically ill trauma patients

2015 ◽  
Vol 79 (4) ◽  
pp. 649-653 ◽  
Author(s):  
Andrew S. Jarrell ◽  
G. Christopher Wood ◽  
Supriya Ponnapula ◽  
Louis J. Magnotti ◽  
Martin A. Croce ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Critically Ill ◽  
Short Duration ◽  
Urinary Tract Infections ◽  
Trauma Patients ◽  
Tract Infections

scholarly journals 1436. Comparison of Ceftazidime–Avibactam, Ceftolozane–Tazobactam, Piperacillin–Tazobactam, and Meropenem Activities When Tested Against Gram-Negative Organisms Isolated From Complicated Urinary Tract Infections

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S524-S524
Author(s):  
Helio S Sader ◽  
Robert K Flamm ◽  
Mariana Castanheira ◽  
Rodrigo E Mendes
Keyword(s):  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Antimicrobial Activities ◽  
Healthcare Associated Infection ◽  
Gram Negative ◽  
Highly Active ◽  
The Us ◽  
Gram Negative Organisms ◽  
Tract Infections ◽  
Esbl Producers

Abstract Background Complicated urinary tract infections (cUTIs) represent a major cause of healthcare-associated infection and a major source of gram-negative (GN) bacteremia. We evaluated the antimicrobial activities of recently approved β-lactamase inhibitor combinations and comparators against GN bacteria isolated from patients with cUTIs in the US hospitals in 2018. Methods Unique patient isolates were consecutively collected from patients with cUTIs in 65 hospitals in 2018, and the GN organisms (n = 4,371) were susceptibility (S) tested by reference broth microdilution methods. Enterobacterales (ENT) with elevated cephalosporin MICs were screened for β-lactamase-encoding genes by whole-genome sequencing. Results The most common GN organisms were E. coli (44.5%), K. pneumoniae (19.6%), P. mirabilis (6.7%), and P. aeruginosa (PSA; 5.3%). The most active agents against ENT were ceftazidime–avibactam (CAZ-AVI; 99.9%S), amikacin (AMK; 99.7%S), and meropenem (MEM; 99.4%S; table). Extended-spectrum β-lactamase (ESBL) genes were identified in 315 ENT (7.6%; excluding carbapenemase co-producers), including CTX-M-15 (63% of ESBL producers), other CTX-M types (25%), OXA-1/OXA-30 (39%), and SHV type (30%); approximately 50% of ESBL producers had ≥2 ESBL genes, mainly a CTX-M-type and an OXA-type (37% of isolates). The most active agents against ESBL producers were CAZ-AVI (100.0%S), AMK (99.7%S), and MEM (99.4%S); whereas ceftolozane–tazobactam (C-T) and piperacillin–tazobactam (PIP-TAZ) were active against 90.6% and 84.8% of ESBL producers, respectively. Only CAZ-AVI (87.0%S), colistin (COL; 87.0%S), and tigecycline (95.7%S) exhibited good activity against carbapenem-resistant ENT (CRE). Only 3 ENT isolates (0.07%) were CAZ-AVI resistant and all had a metallo-β-lactamase gene (2 VIM-1 and 1 NDM-1). CAZ-AVI (97.0%S) and C-T (99.1%S) were the most active β-lactams tested against PSA; other compounds with > 90%S for PSA were COL (99.6%), AMK (97.8%), tobramycin (93.5%), and CAZ (90.4%). Conclusion CAZ-AVI was highly active against a large collection of contemporary GN bacteria isolated from patients with cUTIs in US hospitals and provided greater coverage than the agents currently available in the US to treat cUTIs. Disclosures All authors: No reported disclosures.

Reclassification of Urinary Tract Infections in Critically Ill Trauma Patients: A Time-Dependent Analysis

2003 ◽  
Vol 4 (4) ◽  
pp. 379-385 ◽  
Author(s):  
Grant V. Bochicchio ◽  
Manjari Joshi ◽  
Diane Shih ◽  
Kelly Bochicchio ◽  
Kate Tracy ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Critically Ill ◽  
Urinary Tract Infections ◽  
Time Dependent ◽  
Trauma Patients ◽  
Tract Infections ◽  
Time Dependent Analysis

scholarly journals Catheter-Associated Urinary Tract Infections among Trauma Patients: Poor Quality of Care or Marker of Effective Rescue?

2020 ◽  
Vol 21 (9) ◽  
pp. 752-759
Author(s):  
Husayn A. Ladhani ◽  
Esther S. Tseng ◽  
Jeffrey A. Claridge ◽  
Christopher W. Towe ◽  
Vanessa P. Ho
Keyword(s):  
Quality Of Care ◽  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Poor Quality ◽  
Trauma Patients ◽  
Tract Infections
Sign in / Sign up

Export Citation Format

Share Document